Subgroup analysis suggested that patients with large, localized tumors benefited from the addition of etoposide, whereas patients with metastases did not. There was no difference in EFS between ...

Durvalumab (Imfinzi) with etoposide and either carboplatin or cisplatin is available on the NHS. It is a possible treatment for extensive-stage small-cell lung cancer that has not been treated before ...

Around 2,400 people in England have ES-SCLC, of whom around 1,200 people will be eligible to receive Tecentriq plus carboplatin and etoposide. NICE noted that clinical trial evidence suggests ...